Consumers interact with products and companies through amyriadof channels, including physical stores, search engines, search terms, online advertisements and social networks.
Myriad Genetics (MYGN), a leading developer of molecular diagnostic and therapeutic products, is predictably on track to expand its pipeline and broaden its markets in the U.S. and overseas.